← FDA Drug Approvals (Drugs@FDA)

DIAZEPAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS ISRAEL PHARMA LTD · Approved 2025-11-12

Drug application

FDA Application #
ANDA219320
Application type
Abbreviated New Drug Application (Generic)
Brand name
DIAZEPAM
Generic name
Diazepam
Active ingredients
DIAZEPAM
Dosage form
Spray
Route
—
Marketing status
None (Tentative Approval)
Sponsor
PADAGIS ISRAEL PHARMA LTD
First approval
2025-11-12

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown